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ABSTRACT Population samples from Angola, Mozambique, and S. Tome´ e Prı´ncipe were screened for the TPI gene
promoter variants -5A?G, -8G?A and -24T?G. Three haplotypes were identified in the three populations: the haplo-
type -5A-8G-24T (average frequency 65.3%) and two less common haplotypes -5G-8G-24T (average frequency 24.7%)
and -5G-8A-24T (average frequency 10.0%). A population sample from Central Portugal showed the haplotype -5A-8G-
24T in 139 chromosomes and one subject heterozygous for haplotype -5G-8A-24G. The exact test of sample differentia-
tion among three groups of malaria-infected individuals classified according to the severity of the disease showed no sig-
nificant differences. We confirmed TPI gene diversity in sub-Saharan Africa, but we could not detect any association
between TPI promoter variation and a malarial protective effect. Larger scale epidemiological studies are thus required
to clarify this putative mechanism of natural host defense against this worldwide public health problem. Am. J. Hum.
Biol. 21:118–120, 2009. ' 2008 Wiley-Liss, Inc.
Triosephosphate isomerase (TPI, EC 5.3.1.1) catalyzes
the reversible isomerisation of dihydroxyacetone phos-
phate (DHAP) and glyceraldehyde-3-phosphate (G-3-P).
TPI deficiency is the most severe autosomal recessive dis-
order of the glycolytic pathway, associated with neonatal
jaundice, chronic hemolytic anemia, progressive neuro-
muscular dysfunction, and increase propensity to infec-
tion (Schneider, 2000). Almost all reported cases are of Eu-
ropean origin (15/18) and lethality was common in early
childhood.
TPI gene promoter mutations -5A?G and -8G?A,
within the cap proximal element (CPE), and -24T?G,
within TATA box, occurring essentially in haplotypes -5
alone, -5 -8, and -5 -8 -24, have been identified in popula-
tions with a wide geographical distribution (Humphries
et al., 1999a; Schneider et al., 1998). However, the great-
est diversity was found in sub-Saharan African popula-
tions with variant haplotypes present in more than 40%
subjects (Humphries et al., 1999a; Schneider et al., 1998).
The -5G allele reaches a high frequency in sub-Saharan
African and Oriental populations, and phylogenetic analy-
ses suggest that this may represent the ancestral pro-
moter haplotype (Humphries et al., 1999a).
Functional studies of erythrocyte TPI enzyme activity
showed that -5G mutation does not change TPI activity,
whereas the -8A mutation alone or -8A-24G haplotype
were associated with moderate reduction in the enzyme
activity (Humphries et al., 1999b). Most probably, muta-
tions -8A and -24G disable the binding of transcription
factors to the conserved promoter regions CPE and TATA,
affecting gene transcription (Humphries et al., 1999b).
Malaria was a major selective force in the recent evolu-
tionary history of human genome. The best characterized
protective polymorphisms of human host against malarial
infection involve erythrocyte-specific enzymes among
which G6PD deficient variants (Luzzatto, 2006) and HbS
(Fleming et al., 1979). Other putative selective targets
such as TPI may deserve investigation due to their vari-
ant promoter haplotypes reaching high frequencies in
individuals with African origin associated with subtle
reduction in enzyme activity (Humphries et al., 1999a;
Schneider et al., 1998).
In this study, we examined for the TPI gene promoter
variants -5A?G, -8G?A and -24T?G, three different
sub-Saharan African populations and a European Portu-
guese sample. As the precise biological significance of TPI
promoter sequence variation remains to be elucidated, as
a preliminary study, we tested the TPI haplotype frequen-
cies in three groups of malaria-infected individuals classi-
fied according to the severity of the disease.
MATERIALS AND METHODS
Samples
Whole-blood samples were collected from three African
geographic regions, Mozambique (N 5 13), Angola (N 5
50), S. Tome´ e Prı´ncipe (N 5 65), and from Central Portu-
Contract grant sponsors: CMDT-LA/IHMT (‘‘Prog. de financiamento Plu-
rianual da Unidade de I&D n 58’’ and POCTI/1999/ESP/35789/99, FCT/
MCTES); Centro de Investigac¸a˜o em Antropologia e Sau´de - Universidade
de Coimbra; Fundac¸a˜o para a Cieˆncia e Tecnologia (through POCI Pro-
grama Operacional Cieˆncia e Inovac¸a˜o 2010).
*Correspondence to: Licı´nio Manco, PhD, Departamento de Antropolo-
gia, Universidade de Coimbra, 3000 Coimbra (Portugal).
E-mail: lmanco@antrop.uc.pt
Received 8 May 2008; Revision received 8 July 2008; Accepted 15 July
2008
DOI 10.1002/ajhb.20819
Published online 12 September 2008 in Wiley InterScience (www.
interscience.wiley.com).
AMERICAN JOURNAL OF HUMAN BIOLOGY 21:118–120 (2009)
VC 2008 Wiley-Liss, Inc.
gal (N 5 70). Collection was approved by the local Ethics
Committees and informed consent was obtained.
In Mozambique, sampling took place in the Manhic¸a
district by active search (all individuals were asymptom-
atic at the time of collection) in the dry (August 2001) and
wet (February 2002) seasons as described by Marques
et al. (2005). In Angola, samples were collected from
malaria-patients: malaria outcome were defined as (1)
severe malaria (SM, 25 children) and (2) uncomplicated
malaria (UM, 25 children) according to WHO criteria
(WHO, 2000)
DNA analysis
DNA was obtained from samples of dried blood spots
(Angola and Mozambique) or leukocytes (S. Tome´ e Prı´n-
cipe and Central Portugal) by standard methods. The pro-
moter region of TPI gene was amplified by PCR with pri-
mers 50-GGCCATGGCGGAGGACGGCG-30 (forward) and
50-GCCAGACCCCTCCTCGGCGA-30 (reverse) (Schneider
et al., 1998). PCR products were digested with restriction
enzymes TseI, MscI, and SfcI to examine -5A?G, -8G?A
and -24T?G variants, respectively, as reported by Schnei-
der et al. (1998).
Detection of Plasmodium
Detection of malaria infection and identification of Plas-
modium species was carried out by nested-PCR amplifica-
tion of the small subunit ribosomal RNA genes (Snounou
et al., 1993).
Statistical analysis
Allele frequencies were estimated by gene counting.
Hardy-Weinberg equilibrium probability value, hetero-
zygosity, and exact P values for linkage disequilibrium
(Fisher exact probability test) and for sample differentia-
tion (Raymond and Rousset, 1995) were obtained using
the software package Arlequin, version 3.01 (Excoffier
et al., 2005; http://cmpg.unibe.ch/software/arlequin3/), as
well as the linkage phase from diploid data, by statistical
inference via ELB algorithm.
RESULTS AND DISCUSSION
TPI gene promoter nucleotide substitutions -5A?G,
-8G?A and -24T?G were analyzed on three sub-Saharan
population samples from Angola, Mozambique, and S.
Tome´ e Prı´ncipe. Genotype distribution is shown in Table
1 and individual allele and haplotype frequencies are
shown in Table 2. The observed genotype distributions on
the two polymorphic loci -5 and -8 showed no deviations
from the Hardy-Weinberg equilibrium (P > 0.05).
The most common A allele for the -5 locus shows an av-
erage frequency of 0.65 allowing for the three population
samples from Angola, Mozambique, and S. Tome´ e Prı´n-
cipe; for -8 variant, the most common G allele reach a
mean frequency of 0.90. Only T allele was found at locus
-24.Three haplotypes were identified across the three sub-
Saharan population samples: the haplotype -5A-8G-24T
(average frequency 65.3%) and two less common haplo-
types, -5G-8G-24T (average frequency 24.7%) and -5G-8A-
24T (average frequency 10.0%). Individual allele and hap-
lotype frequencies were similar in the three population
samples (Table 2) and with other sub-Saharan populations
TABLE 1. TPI gene promoter genotype distribution and frequencies found in the population samples from Angola (ANG), Mozambique (MOZ),
and S. Tome´ e Prı´ncipe (STP)
TPI genotypes ANG Frequency (%) MOZ Frequency (%) STP FREQ (%)
-5A/-5A-8G/-8G 20 40.0 3 23.1 36 55.4
-5A/-5G-8G/-8G 17 34.0 7 53.8 14 21.5
-5G/-5G-8G/-8G 3 6.0 1 7.7 0 0
-5A/-5G-8G/-8A 7 14.0 2 15.4 10 15.4
-5G /-5G-8G/-8A 3 6.0 0 0.0 4 6.2
-5G/-5G-8A/-8A 0 0.0 0 0.0 1 1.5
Total 50 100.0 13 100.0 65 100.0
Locus-24 was monomorphic for allele T.
TABLE 2. TPI gene promoter polymorphic sites -5 -8 and -24 allelic and haplotype frequencies in the population samples from Angola (ANG),
Mozambique (MOZ), and S. Tome´ e Prı´ncipe (STP)
Variant n
-5A > G -8G > A -24 T > G Haplotype 5-8-24 Haplotype 5-8-24 Haplotype 5-8-24
A G G A T G AGT GGT GAT
ANG 50 0.640 0.360 0.900 0.100 1.00 0.00 0.640 0.260 0.100
P 1.000 1.000
Ho 0.480 0.200
He 0.478 0.199
MOZ 13 0.577 0.423 0.923 0.077 1.00 0.00 0.577 0.346 0.077
P 0.274 1.000
Ho 0.69 0.15
He 0.50 0.14
STP 65 0.738 0.262 0.877 0.123 1.00 0.00 0.738 0.138 0.124
P 0.750 1.000
Ho 0.369 0.215
He 0.389 0.231
Ho, Observed Heterozygosity; He, Expected Heterozygosity; P, Hardy-Weinberg Equilibrium Probability Value.
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previously studied (Humphries et al., 1999a; Schneider
et al., 1998). Linkage disequilibrium was observed
between loci -5 and -8 in Angola (exact P 5 0.0003 6
0.0001) and S. Tome´ e Prı´ncipe (exact P 5 0.000), but in
Mozambique a P value not statistically significant (exact
P 5 0.70 6 0.004) was found, which may be related with
the small population sample under study (N 5 13). The
exact test of differentiation based on TPI gene promoter
haplotype frequencies showed no significant differences
among the three sub-Saharan populations.
A population sample of 70 individuals from Central Por-
tugal showed the haplotype -5A-8G-24T in 139 chromo-
somes. One individual was found heterozygous with geno-
type -5A/G -8G/A -24T/G, a similar result to Humphries
et al. (1999a) in Mediterranean (N 5 55), Asian Indian
(N 5 48) and Caribbean (N 5 26) population samples
where one heterozygous subject for all the three alleles
was found in each group.
To tentatively provide results concerning the biological
significance of TPI promoter variation, three groups of
malaria-infected individuals from Angola and Mozambi-
que, classified according to the severity of disease with
severe malaria (SM) (25 chromosomes), uncomplicated
malaria (UM) (25 chromosomes), and asymptomatic (AS)
(13 chromosomes) were tested for TPI gene promoter
mutations. Sample differentiation across the three groups
based on -5-8-24 haplotype frequencies showed no statisti-
cal significant differences (exact P values: SM vs. UM 5
0.864 6 0.004; SM vs. AS 5 0.713 6 0.005, and UM vs.
AS 5 0.805 6 0.005). In the same way, using individual
locus -5 and -8 allele frequencies to testing sample differ-
entiation, no significant differences were found (exact P
values between 0.622 and 1.000). These results seems to
indicate that TPI gene promoter variation observed in
sub-Saharan Africa human populations is not associated
with malarial selective influences, validating Humphries
et al. (1999a) results showing that TPI gene diversity pre-
dates the evolutionary period within the 10,000 years of
the malarial selective impact on human populations.
Therefore, the different pattern of TPI gene promoter var-
iation between African and non-African populations could
be related to random demographic events.
In the same way, the exact test of sample differentiation
between two groups from the population sample of S.
Tome´ e Prı´ncipe, classified as infected and noninfected by
the detection of Plasmodium DNA obtained from human
peripheral blood samples, showed to be nonsignificant
(exact P value 0.4346 0.012).
In conclusion, we have confirmed through the analysis
of three population samples from different geographic
regions the diversity of TPI promoter region in sub-
Saharan Africa. Analyzing three groups of Plasmodium
infected individuals classified according to the clinical
phenotype of malaria, we could not detect any association
between the observed TPI promoter variation and a ma-
larial protective effect. However, this still is a preliminary
study and larger scale epidemiological studies are thus
required to clarify if this effect does exist indeed but is too
weak to be detected in samples of modest size. Malaria is
nowadays a serious worldwide public health problem, and
new tools and approaches to control and combat this dis-
ease are urgently needed. These studies may provide
insight into naturally occurring mechanisms of host
defense, which could be used to develop new therapeutic
agents.
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